AGR2 has since been demonstrated to be estrogen [11-13] and androgen responsive [14], and its upregulation has been reported in a number of cancers, including breast, lung, ovarian, gastric, pancreatic, esophageal, and prostate cancer [11,15-25]. This evidence concerns the gene AGR2 and cancer.